| RS1399681796 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS139968311 |
AP3B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 2, Autoinflammatory syndrome |
| RS139969658 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, 6 conditions |
| RS139969671 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS139970401 |
SLC9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital secretory sodium diarrhea 8, Congenital secretory sodium diarrhea 8 |
| RS1399711421 |
CEP57
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 2, Mosaic variegated aneuploidy syndrome 2 |
| RS139971481 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1399717425 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1399720818 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS139972151 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease 4, PSEN2-related disorder |
| RS139972217 |
TMC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermodysplasia verruciformis, susceptibility to |
| RS139972326 |
KIF18A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139973362 |
MFSD2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1399740294 |
PUS1
|
Health Risk |
Likely pathogenic |
— |
| RS139974034 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 8, Inborn genetic diseases |
| RS139974035 |
KRT16
|
Health Risk |
Conflicting classifications of pathogenicity |
KRT16-related disorder, Inborn genetic diseases |
| RS1399741348 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, COL2A1-related disorder |
| RS139974572 |
TUBGCP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139974904 |
GYS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS1399754800 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS139975681 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, Inborn genetic diseases |
| RS139977329 |
SLC5A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS139978727 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1 |
| RS1399788808 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1399789771 |
ITGB3
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1399790840 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS139979318 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Primary familial dilated cardiomyopathy |
| RS139979391 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 10, Leber congenital amaurosis 11 |
| RS139982397 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome, Inborn genetic diseases |
| RS1399824473 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS139983160 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, Cardiomyopathy |
| RS139983909 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS139984206 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hereditary hemochromatosis |
| RS1399847240 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139985214 |
TMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 36 |
| RS1399856074 |
CUBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome type 1, Proteinuria |
| RS139988853 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS1399892057 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS139990077 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS139990565 |
GRIA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Syndromic X-linked intellectual disability 94, Thyroid cancer |
| RS139990606 |
ADAMTSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopia lentis 2, isolated |
| RS1399911403 |
SLC11A2
|
Health Risk |
Pathogenic |
Microcytic anemia with liver iron overload, Microcytic anemia with liver iron overload |
| RS139991163 |
STN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139991238 |
PRKCSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 1, Polycystic liver disease 1 |
| RS1399914687 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS139991645 |
SEPTIN14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139992374 |
TMPRSS15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139992576 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS139993038 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1399931138 |
TSFM
|
Health Risk |
Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS1399932916 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1399941088 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1399954090 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Alport syndrome |
| RS1399955256 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS139995772 |
KIRREL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 23 |
| RS1399958038 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1399970491 |
SPEN
|
Health Risk |
Likely pathogenic |
Radio-Tartaglia syndrome, Radio-Tartaglia syndrome |
| RS139997243 |
ARL13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 8, ARL13B-related disorder |
| RS1399973379 |
ASNS
|
Health Risk |
Likely pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1399979602 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS139998038 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 10, Bardet-Biedl syndrome 14 |
| RS139998082 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, Hereditary xanthinuria type 1 |
| RS139998682 |
UBR4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139999174 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS140000324 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS140000699 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SPTBN2-related disorder |
| RS140002194 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1400022403 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS140002610 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, Intellectual disability |
| RS1400027699 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1400037080 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS140003804 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Early-onset myopathy with fatal cardiomyopathy |
| RS1400042777 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS140004653 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 18 |
| RS140005044 |
ADAMTSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopia lentis 2, isolated |
| RS1400051085 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS140005285 |
TBXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ghosal hematodiaphyseal dysplasia, Ghosal hematodiaphyseal dysplasia |
| RS140005424 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS140005450 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, ATP8B1-related disorder |
| RS1400057476 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS1400065323 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS140009042 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1400104618 |
DOT1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140010463 |
PNPLA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PNPLA8-related disorder |
| RS1400108198 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS140011636 |
STING1
|
Health Risk |
Conflicting classifications of pathogenicity |
STING-associated vasculopathy with onset in infancy, Autoinflammatory syndrome |
| RS1400121444 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1400121541 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS140012391 |
IGSF10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140012781 |
SLC12A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Bartter syndrome |
| RS140013693 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS140014006 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140014115 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS140014632 |
NPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 1, Maroteaux type |
| RS140014925 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Glycogen phosphorylase kinase deficiency |
| RS140015315 |
ITGB6
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1H, Amelogenesis imperfecta type 1H |
| RS140015545 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS1400161680 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Cornelia de Lange syndrome 1 |
| RS140016178 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined pituitary hormone deficiencies, genetic form |
| RS140016265 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |